Sign in with Google
Tigermed (泰格医疗) A+H: Past A+H Listings Suggest Upside Might Be Limited
494 Views27 Jul 2020 07:34
Tigermed, the largest China-based clinical CRO company, launched book building today to raise up to USD 1.4 bn to list in Hong Kong.
In our...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Henderson Land (12 HK): Large Passive Flow Coming Up as Shorts Cover
- Tam Jai (2217 HK): Anxiety Creeps in Ahead of the Scheme Document
- FXI Rebalance: Pop Mart, SF Holding In; China Merchant Sec, China Railway Out
- MBK Partners Plans to Launch a Tender Offer for Makino Milling Machine
- Toyota Motor (7203 JP) Outlook Amid Uncertainty Over Toyota Industries Privatization Bid
Top Unpaywalled Insights
More »- VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
- Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
- [IO Technicals 2025/22] Bearish Momentum Strengthens
- Texas Power Play: Grid Sovereignty, Bitcoin, and the Future of AI
- Overview #27 – The Big Beautiful Tragi-Comedy Continues
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Tigermed (泰格医疗) A+H: Past A+H Listings Suggest Upside Might Be Limited27 Jul 2020
- Tigermed (泰格医疗) A+H: PHIP Updates and Thoughts on Valuation20 Jul 2020
- Tigermed (泰格医疗) A+H Listing: Hot Deal of the Best China Clinical-CRO Play26 Apr 2020
x